Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Dimethyl fumarate - Curacle

Next Previous
Drug Profile

Dimethyl fumarate - Curacle

Alternative Names: CU 01 1001; CU-01; DMF

Latest Information Update: 13 Feb 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Kyungpook National University
  • Developer CURACLE
  • Class Anti-inflammatories; Antihypertensives; Antipsoriatics; Antirheumatics; Cardiovascular therapies; Cytoprotectives; Esters; Fumarates; Small molecules; Urologics
  • Mechanism of Action NF-E2-related factor 2 stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Diabetic nephropathies

Most Recent Events

  • 25 Jan 2023 Curacle initiates a phase II trial for Diabetic nephropathies in South Korea (PO) (NCT05718375)
  • 12 Dec 2022 Dimethyl fumarate is still in phase II trial for Diabetic nephropathies in South Korea (PO, Tablet) (KCT0004233)
  • 08 Aug 2022 Curacle received phase IIb IND approval from the Ministry of Food and Drug Safety of South korea for diabetic nephropathy

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top